The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
出版年份 2020 全文链接
标题
The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
作者
关键词
-
出版物
Journal of Diabetes Research
Volume 2020, Issue -, Pages 1-6
出版商
Hindawi Limited
发表日期
2020-07-10
DOI
10.1155/2020/9368583
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
- (2020) Liang-Kung Chen et al. Journal of the American Medical Directors Association
- Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
- (2019) Hiroyasu Mori et al. Journal of Diabetes Investigation
- AMP-activated protein kinase: the current landscape for drug development
- (2019) Gregory R. Steinberg et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy
- (2019) Anja Schork et al. Cardiovascular Diabetology
- Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The MUSCLES ‐ DM study
- (2019) Ken Sugimoto et al. Journal of Diabetes Investigation
- Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus
- (2019) Noriko Ogama et al. Journal of Clinical Medicine
- Sodium–glucose cotransporter 2 inhibitor and sarcopenia in a lean elderly adult with type 2 diabetes: A case report
- (2019) Megumi Yasuda et al. Journal of Diabetes Investigation
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study
- (2018) Tatsuya Fukuda et al. Cardiovascular Diabetology
- Comparative study of the effects of ipragliflozin and sitagliptin on multiple metabolic variables in Japanese patients with type 2 diabetes: A multicentre, randomized, prospective, open-label, active-controlled study
- (2018) Yuya Tsurutani et al. DIABETES OBESITY & METABOLISM
- MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism?
- (2018) Russell L Esterline et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes
- (2018) Seigo Sugiyama et al. Journal of Atherosclerosis and Thrombosis
- The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis
- (2018) Takahiro Yajima et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease
- (2018) Mitsuko Inoue et al. Journal of Diabetes Investigation
- Ipragliflozin, an SGLT 2 Inhibitor, Reduces Body Weight and Fat Mass, but not Muscle Mass, in Japanese Type 2 Diabetic Patients Treated with Insulin: A Randomized Clinical Trial
- (2018) Hideka Inoue et al. Journal of Diabetes Investigation
- Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice
- (2016) Hiroyuki Sato et al. DIABETOLOGIA
- Sarcopenia in Elderly Diabetic Patients: Role of Dipeptidyl Peptidase 4 Inhibitors
- (2016) Maria Rosaria Rizzo et al. Journal of the American Medical Directors Association
- Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review
- (2016) Lluis Campins et al. PHARMACOLOGY
- Increased grip strength with sodium-glucose cotransporter 2
- (2016) Motoaki Sano et al. Journal of Diabetes
- Reduction in Endogenous Insulin Secretion is a Risk Factor of Sarcopenia in Men with Type 2 Diabetes Mellitus
- (2015) Ken-ichiro Tanaka et al. CALCIFIED TISSUE INTERNATIONAL
- Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events
- (2015) Daisuke Yabe et al. Expert Opinion On Drug Safety
- Combined association of chronic disease and low skeletal muscle mass with physical performance in older adults in the Sarcopenia and Translational Aging Research in Taiwan (START) study
- (2015) Chia-Ing Li et al. BMC Geriatrics
- Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review
- (2014) Sumbul Ali et al. GERONTOLOGY
- Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014
- (2014) John E. Morley et al. Journal of Cachexia Sarcopenia and Muscle
- Glucose deprivation induces reticulum stress by the PERK pathway and caspase-7- and calpain-mediated caspase-12 activation
- (2013) Selene García de la Cadena et al. APOPTOSIS
- Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
- (2013) J. Bolinder et al. DIABETES OBESITY & METABOLISM
- Mechanisms regulating skeletal muscle growth and atrophy
- (2013) Stefano Schiaffino et al. FEBS Journal
- Changes in Physical Performance in Older Women According to Presence and Treatment of Diabetes Mellitus
- (2013) Christine G. Lee et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Resistance Training and Pioglitazone Lead to Improvements in Muscle Power During Voluntary Weight Loss in Older Adults
- (2013) A. P. Marsh et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide-Dependent Mechanism
- (2012) W. Chai et al. DIABETES
- Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats
- (2012) Gisele Giannocco et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network
- (2011) Antero Salminen et al. AGEING RESEARCH REVIEWS
- Insulin Sensitizers May Attenuate Lean Mass Loss in Older Men With Diabetes
- (2011) C. G. Lee et al. DIABETES CARE
- The Effect of Pioglitazone and Resistance Training on Body Composition in Older Men and Women Undergoing Hypocaloric Weight Loss
- (2011) M. Kyla Shea et al. Obesity
- Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS)
- (2010) T. N. Kim et al. DIABETES CARE
- The KATPchannel is a molecular sensor of atrophy in skeletal muscle
- (2010) Domenico Tricarico et al. JOURNAL OF PHYSIOLOGY-LONDON
- Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial
- (2009) D. K. Coletta et al. DIABETOLOGIA
- Diabetes in Asia
- (2009) Juliana C. N. Chan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is There A Relationship Between Insulin Resistance and Frailty Syndrome?
- (2008) Giuseppe Paolisso et al. CURRENT PHARMACEUTICAL DESIGN
- Nuclear factor-kappa B signaling in skeletal muscle atrophy
- (2008) Hong Li et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome
- (2008) Vibe Skov et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search